Kiniksa Pharmaceuticals International, plc

KNSA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $4.1B · 366 employees
129
SEC Filings
$48.43
Close 2026-06-01
366
Employees

Business Summary

PART I . Overview We are a biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Our portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. ARCALYST is an interleukin-1 (IL-1) and interleukin-1 (IL-1) cytokine trap. In 2017, we licensed ARCALYST from Regeneron, which discovered and initially developed the drug. Our exclusive license...

Latest Stock Quote

KNSA 2026-06-01 $48.43 O:$47.84 H:$48.94 L:$46.6301 Vol:0.8M VWAP:$48.1986
origin leaf: b7bc77cfc716c72181e59b9dfb27a09ff172ec6eb35c048d80340b59949af0f7

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001104659-26-019168EDGAR104K words
2025-02-252024-12-310001558370-25-001505EDGAR—
2024-02-282023-12-310001558370-24-002005EDGAR—
2023-03-022022-12-310001558370-23-002684EDGAR—
2022-02-242021-12-310001558370-22-001932EDGAR—
2021-02-252020-12-310001558370-21-001821EDGAR—
2020-03-052019-12-310001558370-20-002081EDGAR—
2019-03-122018-12-310001558370-19-001857EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-282025-09-300001104659-25-103180EDGAR71K words
2025-07-292025-06-300001558370-25-009738EDGAR—
2025-04-292025-03-310001558370-25-005847EDGAR—
2024-10-292024-09-300001558370-24-013840EDGAR—
2024-07-252024-06-300001558370-24-010181EDGAR—
2024-04-252024-03-310001558370-24-005774EDGAR—
2023-11-022023-09-300001558370-23-017423EDGAR—
2023-08-012023-06-300001558370-23-012729EDGAR—
2023-05-042023-03-310001558370-23-008113EDGAR—
2022-11-032022-09-300001558370-22-016250EDGAR—
2022-08-042022-06-300001558370-22-012203EDGAR—
2022-05-052022-03-310001558370-22-007381EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-240001730430-26-000014EDGAR3K words
2026-01-140001730430-26-000010EDGAR—
2026-01-120001730430-26-000005EDGAR—
2025-10-280001104659-25-102834EDGAR—
2025-09-030001104659-25-086689EDGAR—
2025-07-290001104659-25-071413EDGAR—
2025-06-050001104659-25-056665EDGAR—
2025-06-030001104659-25-055990EDGAR—
2025-04-290001104659-25-040641EDGAR—
2025-04-230001104659-25-038041EDGAR—

129 total filings indexed. 99 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001730430
TickerKNSA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
Websitehttps://www.kiniksa.com
Listed2018-05-24

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: ccf4fbcfa6e33c5be87f71b88ceea4b1f0bd784498669895313ba8c308208f14
parent: d0fa25bc9a523d42f7367672e0731c19bd9ed6e2d49b65ca2b684b266aa838c3
content hash: 4b75e6bd9a5b6ec6f990fd440c7a57f0a555fed9f4d8317f3eaab55649fc839a
signed: 2026-06-02T19:01:39.606Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf